These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7879598)

  • 1. bcl-2 protein expression in tumors of the central nervous system.
    Nakasu S; Nakasu Y; Nioka H; Nakajima M; Handa J
    Acta Neuropathol; 1994; 88(6):520-6. PubMed ID: 7879598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.
    Krajewski S; Krajewska M; Ehrmann J; Sikorska M; Lach B; Chatten J; Reed JC
    Am J Pathol; 1997 Mar; 150(3):805-14. PubMed ID: 9060818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone receptor expression in brain tumors.
    Sakoguchi T; Hama S; Tominaga A; Kinoshita Y; Sugiyama K; Arita K; Kurisu K
    Hiroshima J Med Sci; 2012 Mar; 61(1):1-6. PubMed ID: 22702213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors.
    Hara A; Hirose Y; Yoshimi N; Tanaka T; Mori H
    Neurol Res; 1997 Dec; 19(6):623-8. PubMed ID: 9427964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy.
    Krishna M; Smith TW; Recht LD
    J Neurosurg; 1995 Dec; 83(6):1017-22. PubMed ID: 7490615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.
    Karamitopoulou E; Perentes E; Diamantis I
    Acta Neuropathol; 1993; 85(6):611-6. PubMed ID: 8337939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study.
    Schiffer D; Cavalla P; Migheli A; Giordana MT; Chiadò-Piat L
    J Neurooncol; 1996 Feb; 27(2):101-9. PubMed ID: 8699231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of neu/c-erbB-2 in human brain tumors.
    Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
    Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human gliomas with wild-type p53 express bcl-2.
    Alderson LM; Castleberg RL; Harsh GR; Louis DN; Henson JW
    Cancer Res; 1995 Mar; 55(5):999-1001. PubMed ID: 7867012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
    Sasaki T; Lopes MB; Hankins GR; Helm GA
    Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro karyotypic and immunophenotypic characterisation of primitive neuroectodermal tumours: similarities to malignant gliomas.
    Jennings MT; Jennings DL; Ebrahim SA; Johnson MD; Turc-Carel C; Philip T; Philip I; Lapras C; Shapiro JR
    Eur J Cancer; 1992; 28A(4-5):762-6. PubMed ID: 1326305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of genes involved in apoptosis in central nervous system neoplasms.
    Bruggers CS; Fults D; Perkins SL; Coffin CM; Carroll WL
    J Pediatr Hematol Oncol; 1999; 21(1):19-25. PubMed ID: 10029807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
    Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
    Jenkins NC; Rao G; Eberhart CG; Pedone CA; Dubuc AM; Fults DW
    J Neurooncol; 2016 Feb; 126(3):415-24. PubMed ID: 26518543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of classical vs. desmoplastic medulloblastomas.
    Pramanik P; Sharma MC; Mukhopadhyay P; Singh VP; Sarkar C
    Neurol India; 2003 Mar; 51(1):27-34. PubMed ID: 12865511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
    Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
    Ann Pathol; 1983 Sep; 3(3):203-11. PubMed ID: 6354202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytology of primary neoplasms of the central nervous system.
    Watson CW; Hajdu SI
    Acta Cytol; 1977; 21(1):40-7. PubMed ID: 264757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow-through fluorocytophotometry of different brain tumours.
    Lehmann J; Krug H
    Acta Neuropathol; 1980; 49(2):123-32. PubMed ID: 7355677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].
    Kaszper E; Hanzély Z; Szende B; Dabasi G; Garami M; Schuler D; Hauser P
    Magy Onkol; 2008 Dec; 52(4):351-5. PubMed ID: 19068462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.